Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HVO

Hvivo (HVO)

Hvivo Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:HVO
DateTimeSourceHeadlineSymbolCompany
03/07/20251:00AMRNS Regulatory NewshVIVO PLC Director/PDMR ShareholdingLSE:HVOHvivo Plc
02/27/20251:00AMRNS Regulatory NewshVIVO PLC Acquisition of Cryostore for up to £3.2mLSE:HVOHvivo Plc
02/17/202511:54AMAlliance NewsAlliance NewsIN BRIEF: hVIVO signs GBP2 million deal as aims to progress hMPV careLSE:HVOHvivo Plc
02/17/20251:00AMRNS Regulatory NewshVIVO PLC £2m hMPV characterisation study contractLSE:HVOHvivo Plc
02/05/20251:00AMRNS Non-RegulatoryhVIVO PLC Shionogi reports positive RSV trial resultsLSE:HVOHvivo Plc
02/03/202510:37AMAlliance NewsAlliance NewshVIVO wins contract for RSV drug human trial for Inhalon BiopharmaLSE:HVOHvivo Plc
02/03/20251:00AMRNS Regulatory NewshVIVO PLC RSV contract signed with Inhalon BiopharmaLSE:HVOHvivo Plc
01/31/20257:24AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
01/31/20251:00AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
01/29/20255:42AMAlliance NewsAlliance NewshVIVO eyes double-digit revenue rise, announces new acquisitionLSE:HVOHvivo Plc
01/29/20251:01AMRNS Regulatory NewshVIVO PLC Acquisition: two Clinical Research Units from CRSLSE:HVOHvivo Plc
01/29/20251:00AMRNS Regulatory NewshVIVO PLC Trading updateLSE:HVOHvivo Plc
01/27/20255:18AMAlliance NewsAlliance NewshVIVO stock rises in response to vaccine testing contractLSE:HVOHvivo Plc
01/27/20251:00AMRNS Regulatory NewshVIVO PLC LOI signed for Phase 3 Whooping Cough trialLSE:HVOHvivo Plc
01/21/20256:16AMAlliance NewsAlliance NewshVIVO subsidiary hLAB wins largest contract to date with US clientLSE:HVOHvivo Plc
01/21/20251:00AMRNS Regulatory NewshVIVO PLC £3.2m hLAB projectLSE:HVOHvivo Plc
01/14/20251:00AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
01/13/20251:00AMRNS Non-RegulatoryhVIVO PLC hMPV challenge model updateLSE:HVOHvivo Plc
12/12/20241:00AMRNS Non-RegulatoryhVIVO PLC COVID-19 study published in Nature CommunicationsLSE:HVOHvivo Plc
12/10/20241:00AMRNS Regulatory NewshVIVO PLC £11.5m RSV contract and notice of trading updateLSE:HVOHvivo Plc
11/19/20241:00AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
11/06/20241:00AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
11/05/20241:00AMRNS Non-RegulatoryhVIVO PLC Presentation at Jefferies London Healthcare ConfLSE:HVOHvivo Plc
10/11/20241:00AMRNS Regulatory NewshVIVO PLC Long Term Incentive Plan/ PDMR NotificationLSE:HVOHvivo Plc
10/07/20241:00AMRNS Non-RegulatoryhVIVO PLC Positive results from RSV human challenge trialLSE:HVOHvivo Plc
09/30/20241:00AMRNS Non-RegulatoryhVIVO PLC Launch of full suite of hLAB standalone servicesLSE:HVOHvivo Plc
09/24/20241:00AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
09/17/20241:00AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
09/13/20241:00AMRNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
09/10/20249:53AMAlliance NewsAlliance NewshVIVO hails "record" half-year revenue, as profit soars 70% higherLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO